ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1573687
This article is part of the Research TopicAdvances in Oncological Imaging TechniquesView all 15 articles
Deep Learning Radiomics Nomogram Predicts Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma
Provisionally accepted- 1Department of Radiology, First Hospital of Shanxi Medical University, Taiyuan, China
- 2College of Medical Imaging,Shanxi Medical University, TAIYUAN, China
- 3Department of pathology,First Hospital of Shangxi Medical University, TAIYUAN, China
- 4Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Lymph node metastases (LNM) in laryngeal squamous cell carcinoma (LSCC) has been associated with lower survival, but current imaging methods, such as computed tomography (CT), have limited capabilities to identify them. Both conventional radiomics, involving data analysis of high-throughput quantitative features extracted from medical images, as well as deep learning networks, improved LNM diagnostic accuracy in LSCC, but the combination of both approaches has not been fully examined. In this study, we aimed to improve LNM identification in LSCC patients by developing a predictive nomogram, combining deep learning radiomics and clinical imaging features from CT images.: A retrospective analysis of 235 LSCC patients, divided into training (164) and validation (71) sets, was conducted. Radiomics features were extracted from CT images, and 7 machine learning algorithms were used to develop 7 radiomics models, which were combined with deep learning features extracted from the ResNet50 deep learning network to form deep learning radiomics (DLR) models. The optimal DLR model was combined with significant clinical imaging features from CT scans to develop the predictive nomogram for LNM in LSCC.The nomogram, under receiver operating characteristic (ROC) curve analyses, yielded areas under the curve (AUC) values of, respectively, 0.934 and 0.864 for training and validation sets, significantly higher than clinical imaging features (0.832 and 0.817), conventional radiomics (0.861 and 0.818), and DLR (0.913 and 0.864), indicating that it was significantly more accurate in predicting LNM in LSCC patients. Additionally, decision curve analysis found that the nomogram had significantly higher clinical utility than the other 3 models.The predictive nomogram, combining clinical imaging and DLR features, is able to accurately identify LNM in LSCC patients, providing valuable information for non-invasive LN staging and personalized treatment approaches.
Keywords: deep learning, artificial intelligence, Radiomics, Laryngeal cancer, lymph node metastasis
Received: 09 Feb 2025; Accepted: 23 Jul 2025.
Copyright: © 2025 Liang, Li, Dong, Chen, Liang, Huangfu, Jiang and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zengyu Jiang, Department of Radiology, First Hospital of Shanxi Medical University, Taiyuan, China
Sheng He, Department of Radiology, First Hospital of Shanxi Medical University, Taiyuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.